MMedication Read More Eli Lilly Drug Retatrutide Clinical Trial ResultsDecember 17, 2025 Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become…
MMedication Read More Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event riskNovember 28, 2025 1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…
MMedication Read More Weight-loss drugs: From a trickle to a floodNovember 18, 2025 It’s been varyingly called the “fat shot”, “skinny jab” or “magic pill” by politicians and celebrities who’ve put…
MMedication Read More Loss of Appetite May Result in Loss of Margins for Swiggy, Zomato – outlookbusiness.comNovember 7, 2025 Loss of Appetite May Result in Loss of Margins for Swiggy, Zomato outlookbusiness.comThe discovery that launched a new wave…
MMedication Read More Prices of Ozempic vs Mounjaro vs Wegovy: How much they cost in the US, UK, India and around the world |November 1, 2025 Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However,…
MMedication Read More Ozempic vs Mounjaro vs Wegovy: Prices in India vs US and what the research actually showsNovember 1, 2025 Ozempic, Mounjaro, Wegovy: Guide to Weight Loss Injections and Their Cost in India vs US Ozempic, Mounjaro and…
MMedication Read More Karan Johar’s Ozempic joke: What you ought to know about weight loss drugOctober 23, 2025 Ozempic 101: Is it behind Karan Johar’s weight loss? Fact sheet for health enthusiasts on benefits and risks…
MMedication Read More Ozempic coming soon to India: What is it? Benefits, side effects and controversiesOctober 1, 2025 India’s drug controller, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) on 26 September for use…
MMedication Read More Wegovy And Zepbound Cost Effective But They Could Break Drug BudgetsSeptember 11, 2025 The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
MMedication Read More Pricing group says weight-loss drugs becoming more cost-effectiveSeptember 9, 2025 By Deena Beasley (Reuters) -An influential drug pricing watchdog on Tuesday said popular GLP-1 weight-loss injections have become…
HHealth Read More ‘Ozempic Vulva’ Is Leading Some Women To Get Labia Puffing And SurgeryAugust 25, 2025 “Ozempic vulva” is an unoffcial term that women have been using to describe what they’ve been noticing in…
MMedication Read More Poisons Board warns against misuse of Ozempic for weight lossAugust 19, 2025 Pharmacy and Poisons Board CEO Fred Siyoi. [File, Standard] The Pharmacy and Poisons Board…